Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cannabis formulation
- Development stage
- Preclinical
- Lead developer
- Panaxia Pharmaceuticals
- Modality
- Classical Binding Small Molecules → Small Molecules
- Administration
- Inhalation, Sublingual, Oral, Topical, Rectal, Transdermal, Intranasal, Ophthalmic
01
Overview
Panaxia Pharmaceuticals is developing a pharmaceutical-grade cannabis formulation specifically for the treatment of chronic migraine. Currently in the IND-enabling stage, the formulation is designed to modulate the endocannabinoid system by targeting the Cannabinoid receptor 1 (CB1) and Cannabinoid receptor 2 (CB2). These receptors play a significant role in pain processing and neuroinflammation, both of which are central to the pathophysiology of migraines. By utilizing standardized phytocannabinoid ratios, Panaxia aims to provide a consistent therapeutic effect for patients suffering from frequent and severe migraine attacks.
- Other names
- cannabis formulation (chronic migraine)
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on cannabis formulation.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cannabis formulation.